← Open Payments lookup

KAESIDE UNACHUKWU: Open Payments

NPI 1306477906 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,626 in 76 payments from 11 companies in 2025. Trend: 2023 $3,217 · 2024 $2,343 · 2025 $3,626

Food & beverage: $3,626
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$787
E.R. Squibb & Sons, L.L.C.11$562
Otsuka America Pharmaceutical, Inc.7$532
Axsome Therapeutics, Inc.5$399
Teva Pharmaceuticals USA, Inc.6$279
Janssen Pharmaceuticals, Inc7$278
Supernus Pharmaceuticals, Inc.10$238
Alkermes, Inc.4$236
Neurocrine BioSciences, Inc.1$125
Noven Therapeutics, LLC1$107

Products named: CAPLYTA, COBENFY, Auvelity, INVEGA SUSTENNA, ABILIFY MAINTENA, REXULTI, Qelbree, UZEDY.

Industry payments across TX — which companies pay providers there.